After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Alnylam Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Alnylam Pharmaceuticals Inc is $34.71B. A total of 0.89 million shares were traded on the day, compared to an average of 791.08K shares.
In the most recent transaction, Garg Pushkal sold 5,445 shares of ALNY for 300.00 per share on Mar 24 ’25. After the transaction, the CMO & EVP Dev & Med Affairs now owns 20,221 company shares. In a previous transaction on Mar 21 ’25, Garg Pushkal sold 4,321 shares at 285.00 per share. ALNY shares that CMO & EVP Dev & Med Affairs owns now total 20,221.
Among the insiders who sold shares, PYOTT DAVID E I disposed of 7,440 shares on Mar 24 ’25 at a per-share price of $299.00. This resulted in the Director holding 136 shares of ALNY after the transaction. In another insider transaction, PYOTT DAVID E I bought 7,440 shares at $299.00 per share on Mar 24 ’25.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ALNY has a high of $304.39 and a low of $141.98.
As of this writing, ALNY has an earnings estimate of -$0.4 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of $0.51 per share and a lower estimate of -$0.93.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ALNY’s latest balance sheet shows that the firm has $2.44B in Cash & Short Term Investments as of fiscal 2021. There were $997.59M in debt and $695.71M in liabilities at the time. Its Book Value Per Share was $0.52, while its Total Shareholder’s Equity was $588.20M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALNY is Buy with a score of 4.34.
